Description

Oxytocin Parallel Dimer is a synthetic peptide analog of the neurohypophysial hormone oxytocin, characterized by its unique parallel dimeric structure. This molecular configuration is of significant interest for advanced biochemical research and pharmaceutical development, offering a stable model for studying peptide interactions and receptor binding mechanisms. It is primarily utilized by research institutions, pharmaceutical R&D departments, and biotechnology companies focused on neuroendocrinology, peptide chemistry, and the development of novel therapeutic agents.

Application

• Biochemical Research: Serves as a critical reference standard and tool for studying oxytocin receptor (OTR) binding affinity, selectivity, and signal transduction pathways.
• Pharmaceutical R&D: Used in the development and screening of new peptide-based therapeutics targeting social behavior disorders, stress responses, and reproductive health.
• Structure-Activity Relationship (SAR) Studies: The dimeric structure provides insights into the effects of molecular conformation on biological activity and stability.
• Analytical Method Development: Acts as a high-purity calibrant for advanced analytical techniques such as HPLC, LC-MS, and peptide mapping.
• Neuroscience Investigations: Employed in experimental models to explore the role of oxytocin analogs in neural circuitry, social cognition, and emotional regulation.

Basic Information

Product Name	Oxytocin Parallel Dimer
CAS No.	19645-28-4
Molecular Formula	C₈₆H₁₂₂N₂₄O₂₀S₄
Molecular Weight	2008.3 g/mol
Synonyms	1-[(4R,7S,10S,13S,16S,19R,22S,25S,28S,31S,34S,37S,40S,43S)-19-Amino-7-(2-amino-2-oxoethyl)-10,13,16,22,25,28,31,34,37,40,43-undecakis(carboxymethyl)-43-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutyl]-34-carbamoyl-25-(carboxymethyl)-31-(2-guanidinoethyl)-37-(hydroxymethyl)-16-(1H-imidazol-5-ylmethyl)-28-(1-methyl ethyl)-10-(1-methylethyl)-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43-pentadecazacyclotetratetracontane-40-carboxylic acid; Oxytocin Dimer; Parallel Oxytocin Dimer
EINECS	Contact for details

Quality Control

Our Oxytocin Parallel Dimer is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, mass spectrometry for identity confirmation, and amino acid analysis. We provide Certificates of Analysis (COA) detailing all specifications to ensure traceability and compliance with your research or development protocols.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to minimize moisture uptake.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder
Identification (HPLC & MS)	Conforms to reference standard
Assay (HPLC)	≥ 95.0%
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 5.0%
Peptide Content	≥ 80.0%
Single Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.